Moreover, the possibility remains that the increased average value for BChE activity in HNSCC reflects compensatory mechanisms to overcome temporal (or permanent) deficiency (or loss) of AChE [53]. The gene discussed is ACHE; the disease is head and neck squamous cell carcinoma.